Zymosense develops high-end fluorescent transducers and enzyme assays for onsite and high-throughput enzyme measurement. This technology enables precise monitoring of enzymatic activity, facilitating faster decision-making in biotechnology applications.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for measuring enzymatic activity often require laboratory analysis, leading to delays in obtaining results and hindering real-time decision-making in biotechnology processes. Traditional enzyme assays may also lack the sensitivity and throughput needed for efficient monitoring and optimization.
Solution
Zymosense offers advanced enzyme assays and high-end fluorescent transducers designed for rapid, onsite, and high-throughput enzyme measurement. Their technology enables precise and continuous monitoring of enzymatic activity directly within bioreactors or other process environments. By providing real-time data on enzyme performance, Zymosense facilitates faster process optimization, improved product yields, and reduced operational costs. The system's high sensitivity allows for the detection of subtle changes in enzymatic activity, enabling early identification of potential issues and proactive intervention.
Target Audience
Zymosense targets biotechnology companies, research institutions, and other organizations involved in enzyme-based processes, biomanufacturing, and drug discovery.
Features
- High-end fluorescent transducers for real-time monitoring of enzymatic activity
- Advanced enzyme assays optimized for various biotechnology applications
- Onsite measurement capabilities, eliminating the need for laboratory analysis
- High-throughput screening capabilities for efficient enzyme characterization
- Precise and continuous monitoring of enzymatic activity